CRISPR Therapeutics AG 10-Q for FY2025 Q2
CRISPR Therapeutics AG (CRSP)
10-Q
2025-08-04
For: 2025-06-30
View Original
Added on
April 09, 2026
About this 10-Q
CRISPR Therapeutics AG filed this 10-Q on August 4, 2025, covering the quarter ended June 30, 2025 (FY2025 Q2).
Headline figures
Quarter ended June 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $892K
- up 72.5% from $517K a year earlier
- Net loss
- $208.55M
- compared with a net loss of $126.41M a year earlier
- Diluted EPS
- -$2.40
- compared with -$1.49 a year earlier